4/6 0 3 0 3 O
matched 4 11 4 11 O
unit 12 16 12 16 O
, 16 17 16 17 O
cell 18 22 18 22 B-clinical_variable
dose 23 27 23 27 I-clinical_variable
> 28 29 28 29 O
5 29 30 29 30 B-lower_bound
x 31 32 31 32 I-lower_bound
10 33 35 33 35 B-upper_bound
- 35 36 35 36 O
7 36 37 36 37 B-lower_bound
nucleated 38 47 38 47 I-lower_bound
cells 48 53 48 53 I-lower_bound
/ 53 54 53 54 I-lower_bound
kg 54 56 54 56 I-lower_bound

5/6 0 3 57 60 O
matched 4 11 61 68 O
unit 12 16 69 73 O
, 16 17 73 74 O
cell 18 22 75 79 B-clinical_variable
dose 23 27 80 84 I-clinical_variable
> 28 29 85 86 O
4 30 31 87 88 B-lower_bound
x 32 33 89 90 I-lower_bound
10 34 36 91 93 I-lower_bound
- 36 37 93 94 I-lower_bound
7 37 38 94 95 I-lower_bound
nucleated 39 48 96 105 I-lower_bound
cells 49 54 106 111 I-lower_bound
/ 54 55 111 112 I-lower_bound
kg 55 57 112 114 I-lower_bound

6/6 0 3 115 118 O
matched 4 11 119 126 O
unit 12 16 127 131 O
, 16 17 131 132 O
cell 18 22 133 137 B-clinical_variable
dose 23 27 138 142 I-clinical_variable
> 28 29 143 144 O
3 30 31 145 146 B-lower_bound
x 32 33 147 148 I-lower_bound
10 34 36 149 151 I-lower_bound
- 36 37 151 152 I-lower_bound
7 37 38 152 153 I-lower_bound
nucleated 39 48 154 163 I-lower_bound
cells 49 54 164 169 I-lower_bound
/ 54 55 169 170 I-lower_bound
kg 55 57 170 172 I-lower_bound

> 0 1 173 174 O
0.1 1 4 174 177 B-lower_bound
% 4 5 177 178 I-lower_bound
residual 6 14 179 187 B-clinical_variable
cells 15 20 188 193 I-clinical_variable
in 21 23 194 196 O
the 24 27 197 200 O
blast 28 33 201 206 O
gate 34 38 207 211 O
with 39 43 212 216 O
immune 44 50 217 223 O
phenotype 51 60 224 233 O
of 61 63 234 236 O
original 64 72 237 245 O
leukemic 73 81 246 254 O
clone 82 87 255 260 O

> 0 1 261 262 O
1 1 2 262 263 B-lower_bound
cycle 3 8 264 269 O
to 9 11 270 272 O
obtain 12 18 273 279 O
CR 19 21 280 282 B-treatment

Active 0 6 283 289 B-chronic_disease
infection 7 16 290 299 I-chronic_disease
at 17 19 300 302 O
time 20 24 303 307 O
of 25 27 308 310 O
transplantation 28 43 311 326 B-treatment
( 44 45 327 328 O
including 45 54 328 337 O
active 55 61 338 344 B-treatment
infection 62 71 345 354 I-treatment
with 72 76 355 359 O
Aspergillus 77 88 360 371 O
or 89 91 372 374 O
other 92 97 375 380 O
mold 98 102 381 385 O
within 103 109 386 392 O
30 110 112 393 395 B-upper_bound
days 113 117 396 400 I-upper_bound
) 117 118 400 401 O

Acute 0 5 402 407 B-cancer
lymphocytic 6 17 408 419 I-cancer
leukemia 18 26 420 428 I-cancer

Acute 0 5 429 434 B-cancer
myeloid 6 13 435 442 I-cancer
leukemia 14 22 443 451 I-cancer

All 0 3 452 455 O
patients 4 12 456 464 O
must 13 17 465 469 O
be 18 20 470 472 O
in 21 23 473 475 O
CR 24 26 476 478 O
as 27 29 479 481 O
defined 30 37 482 489 O
by 38 40 490 492 O
hematological 41 54 493 506 O
recovery 55 63 507 515 O
, 63 64 515 516 O
AND 65 68 517 520 O
< 69 70 521 522 O
5 70 71 522 523 B-upper_bound
% 71 72 523 524 I-upper_bound
blasts 73 79 525 531 O
by 80 82 532 534 O
light 83 88 535 540 B-treatment
microscopy 89 99 541 551 I-treatment
within 100 106 552 558 O
the 107 110 559 562 O
bone 111 115 563 567 O
marrow 116 122 568 574 O
with 123 127 575 579 O
a 128 129 580 581 O
cellularity 130 141 582 593 B-clinical_variable
of 142 144 594 596 O
≥15 145 148 597 600 O
% 148 149 600 601 I-lower_bound

All 0 3 602 605 O
patients 4 12 606 614 O
must 13 17 615 619 O
be 18 20 620 622 O
in 21 23 623 625 O
CR 24 26 626 628 O
or 27 29 629 631 O
early 30 35 632 637 O
relapse 36 43 638 645 O
( 44 45 646 647 O
i.e. 45 49 647 651 O
, 49 50 651 652 O
< 51 52 653 654 O
15 52 54 654 656 B-upper_bound
% 54 55 656 657 I-upper_bound
blasts 56 62 658 664 B-clinical_variable
in 63 65 665 667 I-clinical_variable
BM 66 68 668 670 I-clinical_variable
) 68 69 670 671 O

Blasts 0 6 672 678 B-clinical_variable
must 7 11 679 683 O
be 12 14 684 686 O
< 15 16 687 688 O
10 17 19 689 691 B-upper_bound
% 19 20 691 692 I-upper_bound
by 21 23 693 695 O
a 24 25 696 697 O
representative 26 40 698 712 O
bone 41 45 713 717 O
marrow 46 52 718 724 O
aspirate 53 61 725 733 O
morphology 62 72 734 744 O

Evidence 0 8 745 753 O
of 9 11 754 756 O
active 12 18 757 763 O
extramedullary 19 33 764 778 B-chronic_disease
disease 34 41 779 786 I-chronic_disease
( 42 43 787 788 O
including 43 52 788 797 O
central 53 60 798 805 B-cancer
nervous 61 68 806 813 I-cancer
system 69 75 814 820 I-cancer
leukemia 76 84 821 829 I-cancer
) 84 85 829 830 O

High 0 4 831 835 O
risk 5 9 836 840 O
cytogenetics 10 22 841 853 O
t(4;11 23 29 854 860 O
) 29 30 860 861 O
or 31 33 862 864 O
other 34 39 865 870 O
MLL 40 43 871 874 B-cancer
rearrangements 44 58 875 889 O

History 0 7 890 897 O
of 8 10 898 900 O
HIV 11 14 901 904 B-chronic_disease
infection 15 24 905 914 O
or 25 27 915 917 O
known 28 33 918 923 O
positive 34 42 924 932 O
serology 43 51 933 941 B-treatment

Lansky 0 6 942 948 B-clinical_variable
score 7 12 949 954 I-clinical_variable
≥ 13 14 955 956 O
50 15 17 957 959 B-lower_bound
% 17 18 959 960 I-lower_bound
and 19 22 961 964 O
have 23 27 965 969 O
acceptable 28 38 970 980 O
organ 39 44 981 986 O
function 45 53 987 995 O

Matched 0 7 996 1003 O
sibling 8 15 1004 1011 O
donor 16 21 1012 1017 O
( 22 23 1018 1019 O
HLA 23 26 1019 1022 B-clinical_variable
8/8 27 30 1023 1026 O
) 30 31 1026 1027 O
, 31 32 1027 1028 O
if 33 35 1029 1031 O
available 36 45 1032 1041 O
, 45 46 1041 1042 O
or 47 49 1043 1045 O
a 50 51 1046 1047 O
unrelated 52 61 1048 1057 O
partially 62 71 1058 1067 O
HLA 72 75 1068 1071 O
matched 76 83 1072 1079 O
single 84 90 1080 1086 O
unit 91 95 1087 1091 O
based 96 101 1092 1097 O
on 102 104 1098 1100 O
the 105 108 1101 1104 O
following 109 118 1105 1114 O
priority 119 127 1115 1123 O

Myeloablative 0 13 1124 1137 B-treatment
transplant 14 24 1138 1148 I-treatment
within 25 31 1149 1155 O
the 32 35 1156 1159 O
last 36 40 1160 1164 B-upper_bound
6 41 42 1165 1166 I-upper_bound
months 43 49 1167 1173 I-upper_bound

Myelodysplasia 0 14 1174 1188 B-cancer
( 15 16 1189 1190 I-cancer
MDS 16 19 1190 1193 I-cancer
) 19 20 1193 1194 I-cancer
IPSS 21 25 1195 1199 O
Int-2 26 31 1200 1205 O
or 32 34 1206 1208 O
High 35 39 1209 1213 O
risk 40 44 1214 1218 O
( 45 46 1219 1220 O
i.e. 46 50 1220 1224 O
RAEB 51 55 1225 1229 B-cancer
, 55 56 1229 1230 O
RAEBt 57 62 1231 1236 B-cancer
) 62 63 1236 1237 O
or 64 66 1238 1240 O
refractory 67 77 1241 1251 B-chronic_disease
anemia 78 84 1252 1258 I-chronic_disease
with 85 89 1259 1263 O
severe 90 96 1264 1270 O
pancytopenia 97 109 1271 1283 B-chronic_disease
or 110 112 1284 1286 O
high 113 117 1287 1291 O
risk 118 122 1292 1296 O
cytogenetics 123 135 1297 1309 O

Patients 0 8 1310 1318 O
aged 9 13 1319 1323 B-age
≤ 14 15 1324 1325 O
3 16 17 1326 1327 B-upper_bound
years 18 23 1328 1333 I-upper_bound
at 24 26 1334 1336 O
diagnosis 27 36 1337 1346 O
( 37 38 1347 1348 O
not 38 41 1348 1351 O
age 42 45 1352 1355 O
of 46 48 1356 1358 O
transplant 49 59 1359 1369 B-treatment
) 59 60 1369 1370 O
with 61 65 1371 1375 O
hematological 66 79 1376 1389 B-cancer
malignancy 80 90 1390 1400 I-cancer

Patients 0 8 1401 1409 O
with 9 13 1410 1414 O
evidence 14 22 1415 1423 O
of 23 25 1424 1426 O
minimal 26 33 1427 1434 B-cancer
residual 34 42 1435 1443 I-cancer
disease 43 50 1444 1451 I-cancer
at 51 53 1452 1454 O
the 54 57 1455 1458 O
completion 58 68 1459 1469 O
of 69 71 1470 1472 O
therapy 72 79 1473 1480 B-treatment
or 80 82 1481 1483 O
evidence 83 91 1484 1492 O
of 92 94 1493 1495 O
rising 95 101 1496 1502 O
MRD 102 105 1503 1506 B-cancer
while 106 111 1507 1512 O
on 112 114 1513 1515 O
therapy 115 122 1516 1523 O
. 122 123 1523 1524 O
MRD 124 127 1525 1528 O
will 128 132 1529 1533 O
be 133 135 1534 1536 O
defined 136 143 1537 1544 O
by 144 146 1545 1547 O
either 147 153 1548 1554 O
flow 154 158 1555 1559 B-treatment
cytometry 159 168 1560 1569 I-treatment

Persistent 0 10 1570 1580 O
or 11 13 1581 1583 O
rising 14 20 1584 1590 O
minimal 21 28 1591 1598 B-cancer
residual 29 37 1599 1607 I-cancer
disease 38 45 1608 1615 I-cancer
( 46 47 1616 1617 I-cancer
MRD 47 50 1617 1620 I-cancer
) 50 51 1620 1621 I-cancer
after 52 57 1622 1627 O
standard 58 66 1628 1636 O
chemotherapy 67 79 1637 1649 B-treatment
regimens 80 88 1650 1658 I-treatment
: 88 89 1658 1659 O

Preceding 0 9 1660 1669 O
myelodysplastic 10 25 1670 1685 B-chronic_disease
syndrome 26 34 1686 1694 I-chronic_disease
( 35 36 1695 1696 I-chronic_disease
MDS 36 39 1696 1699 I-chronic_disease
) 39 40 1699 1700 I-chronic_disease

bilirubin 0 9 1701 1710 B-clinical_variable
, 9 10 1710 1711 O
AST 11 14 1712 1715 B-clinical_variable
/ 14 15 1715 1716 O
ALT 15 18 1716 1719 B-clinical_variable
, 18 19 1719 1720 O
ALP 20 23 1721 1724 B-clinical_variable
< 24 25 1725 1726 O
5 26 27 1727 1728 B-upper_bound
x 28 29 1729 1730 I-upper_bound
upper 30 35 1731 1736 I-upper_bound
limit 36 41 1737 1742 I-upper_bound
of 42 44 1743 1745 I-upper_bound
normal 45 51 1746 1752 I-upper_bound

by 0 2 1753 1755 O
molecular 3 12 1756 1765 B-treatment
techniques 13 23 1766 1776 I-treatment
( 24 25 1777 1778 I-treatment
PCR 25 28 1778 1781 I-treatment
or 29 31 1782 1784 I-treatment
FISH 32 36 1785 1789 I-treatment
) 36 37 1789 1790 I-treatment
or 38 40 1791 1793 O
conventional 41 53 1794 1806 B-treatment
cytogenetics 54 66 1807 1819 I-treatment
( 67 68 1820 1821 I-treatment
g 68 69 1821 1822 I-treatment
- 69 70 1822 1823 I-treatment
banding 70 77 1823 1830 I-treatment
) 77 78 1830 1831 I-treatment

chromosome 0 10 1832 1842 B-clinical_variable
5 11 12 1843 1844 B-lower_bound
, 12 13 1844 1845 O
7 14 15 1846 1847 O
, 15 16 1847 1848 O
or 17 19 1849 1851 O
19 20 22 1852 1854 B-upper_bound
abnormalities 23 36 1855 1868 O

complex 0 7 1869 1876 B-clinical_variable
karyotype 8 17 1877 1886 I-clinical_variable

glomerial 0 9 1887 1896 B-clinical_variable
filtration 10 20 1897 1907 I-clinical_variable
rate 21 25 1908 1912 I-clinical_variable
> 26 27 1913 1914 O
60ml 28 32 1915 1919 B-lower_bound
/ 32 33 1919 1920 I-lower_bound
min/1.73m^2 33 44 1920 1931 I-lower_bound

high 0 4 1932 1936 O
risk 5 9 1937 1941 O
CR1 10 13 1942 1945 B-chronic_disease

hypodiploid 0 11 1946 1957 B-cancer
; 11 12 1957 1958 O
t(9;22 13 19 1959 1965 O
) 19 20 1965 1966 O

left 0 4 1967 1971 B-clinical_variable
ventricular 5 16 1972 1983 I-clinical_variable
ejection 17 25 1984 1992 I-clinical_variable
fraction 26 34 1993 2001 I-clinical_variable
> 35 36 2002 2003 O
45 37 39 2004 2006 B-lower_bound
% 39 40 2006 2007 I-lower_bound

oxygen 0 6 2008 2014 B-clinical_variable
saturation 7 17 2015 2025 I-clinical_variable
> 18 19 2026 2027 O
92 19 21 2027 2029 B-lower_bound
% 21 22 2029 2030 I-lower_bound

t(4;11 0 6 2031 2037 O
) 6 7 2037 2038 O
or 8 10 2039 2041 O
other 11 16 2042 2047 O
MLL 17 20 2048 2051 B-cancer
rearrangements 21 35 2052 2066 O

≥ 0 1 2067 2068 O
2 2 3 2069 2070 B-lower_bound
cycles 4 10 2071 2077 O
to 11 13 2078 2080 O
obtain 14 20 2081 2087 O
complete 21 29 2088 2096 B-clinical_variable
response 30 38 2097 2105 I-clinical_variable
( 39 40 2106 2107 I-clinical_variable
CR 40 42 2107 2109 I-clinical_variable
) 42 43 2109 2110 I-clinical_variable
; 43 44 2110 2111 O
CR2 45 48 2112 2115 B-clinical_variable
or 49 51 2116 2118 O
higher 52 58 2119 2125 O

